Clinical Trials Logo

Clinical Trial Summary

The objective of this study is to determine if the use of a new type of barbed suture material for laparoscopic myomectomy (surgical removal of fibroids) versus the traditional approach of suturing with conventional suture material to close the uterine defect once the fibroid has been removed, improves surgical outcomes. Specifically, the investigators will investigate the effect of barbed suture on operative time, blood loss, adverse post-operative events and hospital stay.


Clinical Trial Description

Although the laparoscopic myomectomy has benefits over the abdominal approach, such as less blood loss, less hemoglobin drop post-operatively, decreased post-operative pain and fewer overall complications, it is a difficult procedure, which often requires greater operative time to perform. In the current climate of attempting to reduce health care expenditures, even though the minimally invasive approach offers the advantage of reduced hospital stay, a deterrent for hospital administration and surgeons may be the increased operative time it may require. Barbed suture is a relatively new material available in gynecologic surgery. Barbs are cut into the suture with the barbs facing in a direction opposite that of the needle. The barbs allow for anchoring of the suture in tissues, which prevents migration and allows suturing without knot tying. This study will be a single-centre non-blinded randomized controlled trial comparing laparoscopic myomectomy with barbed suture versus traditional suture material. ;


Study Design

Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT01347385
Study type Interventional
Source Sunnybrook Health Sciences Centre
Contact Jamie Kroft, MD, FRCSC
Phone 416-480-6100
Email jamie.kroft@utoronto.ca
Status Not yet recruiting
Phase N/A
Start date January 2012

See also
  Status Clinical Trial Phase
Not yet recruiting NCT05568940 - Evaluating Tibolone Add-back in Patients With Endometriosis and Fibroids
Terminated NCT02209545 - Misoprostol for Reduction of Blood Loss During Fibroid Surgery Phase 4
Completed NCT00332033 - Development of a Non-Invasive Treatment for Uterine Leiomyoma (Fibroids) Phase 2
Recruiting NCT04849858 - Pilot Study of Liposomal Bupivacaine Redosing in Patients Undergoing Major Gynecologic Procedures Phase 3
Terminated NCT00001850 - Evaluation of Women With Endocrine and Reproductive-Related Conditions
Completed NCT02620748 - Use of Intravenous Tranexamic Acid During Myomectomy Phase 1
Completed NCT02954744 - High-intensity Focused Ultrasound in Treatment of Uterine Fibroid N/A
Terminated NCT00710346 - Establishment of Fibroid Tissue Bank
Withdrawn NCT02703246 - Tissue Removal During Hysterectomy: The Effect of Vaginal Versus Abdominal Morcellation on Surgical Outcomes N/A
Completed NCT02620345 - Fibroids in Women of Reproductive Age and Women Pregnancy Phase 4
Completed NCT01581944 - Gonadotropin-releasing Hormone Agonist Prior to Myomectomy Phase 3
Completed NCT04071574 - Comparative Study on the Efficacy of Ovarian Stimulation Protocols on the Success Rate of ICSI in Female Infertility Phase 1/Phase 2
Completed NCT02812186 - Deep Versus Moderate Neuromuscular Blockade During Laparoscopic Surgery Phase 4
Recruiting NCT02288130 - Ulipristal vs. GnRHa Prior to Laparoscopic Myomectomy Phase 4
Completed NCT04550429 - Uterine Filling Pressure in Hysteroscopy N/A
Withdrawn NCT01671215 - Endometrial and Myometrial Changes, With and Without Fibroids N/A
Completed NCT01936493 - Biologic Predictors of Leiomyoma Treatment Outcomes N/A
Completed NCT00995878 - The FIRSTT: Comparing MRgFUS(MR-guided Focused Ultrasound) Versus UAE (Uterine Artery Embolization)for Uterine Fibroids. Phase 4